GGrantIndex
← Leaderboards

Russell S Taichman

University Of Michigan At Ann Arbor

Google Scholar ↗PubMed ↗ORCID ↗
$8,193,509
Attributed
$9,889,389
Total exposure
13
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY2005–24
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$12,858,788 · 14

By mechanism

P01$4,266,280 · 4
U54$4,265,171 · 3
R01$2,835,359 · 3
RC1$971,456 · 1
R44$411,776 · 1
R43$108,746 · 1

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Bone Marrow”

Research focus

Bone MarrowCellsMarrowHematopoietic Stem CellsMalignant Neoplasm Of ProstateMetastatic Neoplasm To The BoneMolecularBoneIn VivoNeoplasm MetastasisNeoplastic CellGrowthTissuesTumorOsteoblastsBiologyReceptorStem Cell NichePathway InteractionsInnovationPlaySignal TransductionMetastatic Prostate CancerAnimals

Grant awards (48)

Project 2: Abscisic Acid Regulates Dormancy of Disseminated Tumor Cells in Bone Marrow$150,928
P01 · FY2024 · CA · contact PI
Project 2: Abscisic Acid Regulates Dormancy of Disseminated Tumor Cells in Bone Marrow$158,897
P01 · FY2023 · CA · contact PI
Project 2: Abscisic Acid Regulates Dormancy of Disseminated Tumor Cells in Bone Marrow$155,079
P01 · FY2022 · CA · contact PI
Project 2: Abscisic Acid Regulates Dormancy of Disseminated Tumor Cells in Bone Marrow$159,678
P01 · FY2021 · CA · contact PI
Project 2: Abscisic Acid Regulates Dormancy of Disseminated Tumor Cells in Bone Marrow$173,709
P01 · FY2020 · CA · contact PI
Regulation of the PCa Metastatic Phenotype by the HSC Niche$344,876
P01 · FY2019 · CA · contact PI
Regulation of the PCa Metastatic Phenotype by the HSC Niche$355,543
P01 · FY2018 · CA · contact PI
Regulation of the PCa Metastatic Phenotype by the HSC Niche$311,965
P01 · FY2017 · CA · contact PI
Regulation of the PCa Metastatic Phenotype by the HSC Niche$313,055
P01 · FY2016 · CA · contact PI
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche$833,270
U54 · FY2015 · CA · contact PI
Mechanisms That Regulate Dormancy of Disseminated Tumor Cells in the Bone Marrow$260,392
U54 · FY2015 · CA · contact PI
Regulation of the PCa Metastatic Phenotype by the HSC Niche$180,989
P01 · FY2015 · CA · contact PI
Administrative Core$124,988
U54 · FY2015 · CA · contact PI
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche$495,498
U54 · FY2014 · CA · contact PI
Mechanisms That Regulate Dormancy of Disseminated Tumor Cells in the Bone Marrow$154,845
U54 · FY2014 · CA · contact PI
Administrative Core$74,324
U54 · FY2014 · CA · contact PI
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche$487,171
U54 · FY2013 · CA · contact PI
Mechanisms That Regulate Dormancy of Disseminated Tumor Cells in the Bone Marrow$268,895
U54 · FY2013 · CA · contact PI
Prostate Cancer Parasitism of the HSC "niche" as a Molecular Mechanism for Ost$207,160
P01 · FY2013 · CA · contact PI
Administrative Core$129,066
U54 · FY2013 · CA · contact PI
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche$612,460
U54 · FY2012 · CA · contact PI
Repair of Bone Defects with Human Autologous Pluripotent Very Small Embryonic lik$411,776
R44 · FY2012 · DE
FunctionalCharacterization of the Stem Cell Niche$360,857
R01 · FY2012 · DK
Prostate Cancer Parasitism of the HSC "niche" as a Molecular Mechanism for Ost$220,238
P01 · FY2012 · CA · contact PI
Mechanisms That Regulate Dormancy of Disseminated Tumor Cells in the Bone Marrow$191,393
U54 · FY2012 · CA · contact PI
Administrative Core$91,869
U54 · FY2012 · CA · contact PI
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche$541,000
U54 · FY2011 · CA · contact PI
FunctionalCharacterization of the Stem Cell Niche$360,857
R01 · FY2011 · DK
Prostate Cancer Parasitism of the HSC "niche" as a Molecular Mechanism for Ost$220,142
P01 · FY2011 · CA · contact PI
The Use of Erythropoietin to Reprogram Oral and Craniofacial Stem Cells$485,544
RC1 · FY2010 · DE · contact PI
FunctionalCharacterization of the Stem Cell Niche$364,502
R01 · FY2010 · DK
Prostate Cancer Parasitism of the HSC "niche" as a Molecular Mechanism for Ost$226,952
P01 · FY2010 · CA · contact PI
The Use of Erythropoietin to Reprogram Oral and Craniofacial Stem Cells$485,912
RC1 · FY2009 · DE · contact PI
FunctionalCharacterization of the Stem Cell Niche$352,488
R01 · FY2009 · DK
Prostate Cancer Parasitism of the HSC "niche" as a Molecular Mechanism for Ost$221,716
P01 · FY2009 · CA · contact PI
Repair of boney defects by human stem cells$108,746
R43 · FY2009 · AR
Role of SDF-1/CSCR4 in bone metastasis$238,473
P01 · FY2008 · CA · contact PI
Role of SDF-1/CSCR4 in bone metastasis$236,493
P01 · FY2007 · CA · contact PI
Role of SDF-1/CSCR4 in bone metastasis$134,392
P01 · FY2006 · CA · contact PI
Role of SDF-1/CSCR4 in bone metastasis$124,942
P01 · FY2005 · CA
Bone and the Hematopoietic System$279,285
R01 · FY2004 · DE
Role of SDF-1/CSCR4 in bone metastasis$131,053
P01 · FY2004 · CA
The Role of Chemokines in Metastatic Prostate Cancer$283,049
R01 · FY2003 · DK
Bone and the Hematopoietic System$279,285
R01 · FY2003 · DE
Bone and the Hematopoietic System$279,285
R01 · FY2002 · DE
Bone and the Hematopoietic System$275,751
R01 · FY2001 · DE
Mechanisms of bone metastases$0
P30 · FY2001 · AR
Mechanisms of bone metastases$0
P30 · FY2001 · AR